vs
Side-by-side financial comparison of LandBridge Co LLC (LB) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $31.1M, roughly 1.8× LIFECORE BIOMEDICAL, INC. \DE\). LandBridge Co LLC runs the higher net margin — 14.2% vs -32.1%, a 46.3% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -4.5%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $25.0K). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LB vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $56.8M | $31.1M |
| Net Profit | $8.1M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 60.0% | -9.9% |
| Net Margin | 14.2% | -32.1% |
| Revenue YoY | 55.6% | -4.5% |
| Net Profit YoY | -83.7% | -52.0% |
| EPS (diluted) | $0.24 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.8M | — | ||
| Q3 25 | $50.8M | $31.1M | ||
| Q2 25 | $47.5M | — | ||
| Q1 25 | $44.0M | $35.2M | ||
| Q4 24 | $36.5M | $32.6M | ||
| Q3 24 | $28.5M | $24.7M | ||
| Q2 24 | $26.0M | — | ||
| Q1 24 | $19.0M | $35.7M |
| Q4 25 | $8.1M | — | ||
| Q3 25 | $8.1M | $-10.0M | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $6.5M | $-14.8M | ||
| Q4 24 | $49.3M | $-6.6M | ||
| Q3 24 | $2.7M | $-16.2M | ||
| Q2 24 | $-57.7M | — | ||
| Q1 24 | $10.8M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 60.0% | — | ||
| Q3 25 | 60.8% | -9.9% | ||
| Q2 25 | 60.0% | — | ||
| Q1 25 | 57.0% | -25.7% | ||
| Q4 24 | 49.4% | -6.0% | ||
| Q3 24 | 11.2% | -46.9% | ||
| Q2 24 | -197.4% | — | ||
| Q1 24 | 71.1% | -2.5% |
| Q4 25 | 14.2% | — | ||
| Q3 25 | 15.9% | -32.1% | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 14.7% | -42.0% | ||
| Q4 24 | 135.2% | -20.2% | ||
| Q3 24 | 9.3% | -65.7% | ||
| Q2 24 | -222.1% | — | ||
| Q1 24 | 56.7% | 43.8% |
| Q4 25 | $0.24 | — | ||
| Q3 25 | $0.26 | $-0.29 | ||
| Q2 25 | $0.24 | — | ||
| Q1 25 | $0.20 | $-0.47 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | $-0.04 | $-0.53 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.7M | $18.9M |
| Total DebtLower is stronger | $570.7M | $136.0M |
| Stockholders' EquityBook value | $340.3M | $-10.5M |
| Total Assets | $1.4B | $235.2M |
| Debt / EquityLower = less leverage | 1.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.7M | — | ||
| Q3 25 | $28.3M | $18.9M | ||
| Q2 25 | $20.3M | — | ||
| Q1 25 | $14.9M | $5.4M | ||
| Q4 24 | $37.0M | $9.5M | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $24.6M | — | ||
| Q1 24 | — | — |
| Q4 25 | $570.7M | — | ||
| Q3 25 | $366.1M | $136.0M | ||
| Q2 25 | $370.9M | — | ||
| Q1 25 | $375.5M | $124.9M | ||
| Q4 24 | $385.5M | $111.3M | ||
| Q3 24 | $242.4M | $106.3M | ||
| Q2 24 | $360.8M | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $340.3M | — | ||
| Q3 25 | $272.0M | $-10.5M | ||
| Q2 25 | $266.4M | — | ||
| Q1 25 | $217.0M | $2.2M | ||
| Q4 24 | $211.8M | $15.4M | ||
| Q3 24 | $97.2M | $-3.9M | ||
| Q2 24 | $296.4M | — | ||
| Q1 24 | $162.3M | $17.7M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.1B | $235.2M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.0B | $237.7M | ||
| Q4 24 | $1.0B | $255.4M | ||
| Q3 24 | $689.9M | $246.8M | ||
| Q2 24 | $710.5M | — | ||
| Q1 24 | — | $246.2M |
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.73× | 56.05× | ||
| Q4 24 | 1.82× | 7.20× | ||
| Q3 24 | 2.49× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $1.8M |
| Free Cash FlowOCF − Capex | $122.0M | $25.0K |
| FCF MarginFCF / Revenue | 214.9% | 0.1% |
| Capex IntensityCapex / Revenue | 7.5% | 5.6% |
| Cash ConversionOCF / Net Profit | 15.68× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.7M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | — | ||
| Q3 25 | $34.9M | $1.8M | ||
| Q2 25 | $37.3M | — | ||
| Q1 25 | $15.9M | $1.2M | ||
| Q4 24 | $67.6M | $-6.1M | ||
| Q3 24 | $7.5M | $-613.0K | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $17.2M | $-1.4M |
| Q4 25 | $122.0M | — | ||
| Q3 25 | $33.7M | $25.0K | ||
| Q2 25 | $36.1M | — | ||
| Q1 25 | $15.8M | $-4.3M | ||
| Q4 24 | $66.7M | $-8.6M | ||
| Q3 24 | $7.1M | $-4.0M | ||
| Q2 24 | $15.7M | — | ||
| Q1 24 | $17.1M | $-7.8M |
| Q4 25 | 214.9% | — | ||
| Q3 25 | 66.3% | 0.1% | ||
| Q2 25 | 75.9% | — | ||
| Q1 25 | 36.0% | -12.1% | ||
| Q4 24 | 182.6% | -26.3% | ||
| Q3 24 | 25.1% | -16.3% | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 90.1% | -21.8% |
| Q4 25 | 7.5% | — | ||
| Q3 25 | 2.3% | 5.6% | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 0.2% | 15.5% | ||
| Q4 24 | 2.7% | 7.5% | ||
| Q3 24 | 1.1% | 13.9% | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 0.5% | 17.8% |
| Q4 25 | 15.68× | — | ||
| Q3 25 | 4.31× | — | ||
| Q2 25 | 4.98× | — | ||
| Q1 25 | 2.46× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 2.80× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.60× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LB
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
